Skip to main content
. 2017 Sep 11;7:11242. doi: 10.1038/s41598-017-11687-y

Figure 8.

Figure 8

Evaluation of the side effects of RGD-hylin a1-HMS in vivo. All data was presented as the means + SD, n = 3, *p < 0.05, **p < 0.01, ***p < 0.001. (A,B) Biochemical analyses of glutamate pyruvate transaminase (ALT) and glutamic-oxalacetic transaminease (AST). (C,D) Blood hemanalysis of red blood cells (RBC) and hemoglobin (HGB).